CPD On-Line
CPD On-Line
Hartley Taylor are working to bring you CPD education and now have presentations for you to review with points awarded for CPD accreditation. We will focus on many disease areas, conferences that will be virtual as updates, and bring you valuable information on new products entering the UK market.

Myeloproliferative Neoplasms Advances Day 2023 – Friday 17th November 2023:
6 CPD points
More Details
Challenging myelofibrosis cases
Dr Jen O’Sullivan, University of Oxford & GSTT
When to take an MF patient to BMT
Dr Juan Carlos Hernández-Boluda, Hospital Clínico of Valencia
Eosinophilia with ASXL mutation – a case
Dr Rebecca Frewin, Gloucestershire Hospitals
Indolent mastocytosis – case-based discussion
Dr Deepti Radia, Guy’s and St Thomas’ Hospital, London
Immunotherapy for MPN options now and in pipeline
Professor Beth Psaila, University of Oxford
Update on prognostic models in MPN focus on MF
Professor Francesco Passamonti, University of Milan
Modern management of myelofibrosis
Professor Serge Verstovsek, Chief Medical Officer, Kartos Therapeutics, California
A new era of therapy for PV
Professor Mary Frances McMullin, Queen’s University Belfast
Technological advances in assessment of MPN
Dr Patrick Harrington, Guy’s and St Thomas’ Hospital, London
Can we move to molecular monitoring in MPN?
Professor Adam Mead, University of Oxford
Blast phase MPN and relevant AML management
Professor Steve Knapper, University Hospital of Wales, Cardiff
New treatments for MPN
Dr Claire Harrision, Guy’s and St Thomas’ Hospital, London
When does a patient with a high Hb need to be managed by a haematologist?
Dr Claire Harrision, Guy’s and St Thomas’ Hospital, London
Triple negative thrombocytosis
Dr Anna Godfrey, Addenbrooke’s Hospital, Cambridge
Important updates for the MPN clinician: cardiology
Dr Alex Lyon, Royal Brompton Hospital
Important updates for the MPN clinician: endocrine
Dr Yaasir Mamoojee, Newcastle Upon Tyne Hospitals
Registration is free of charge

CLL Study Day for Nurses “Living with CLL”:
November 2023
More Details
The programme for the second CLL Study Day for Nurses will provide nurses and allied health professionals working in this disease area with a useful opportunity to share latest data and best practice, keep up-to-date with changes in practice and lots more.

Experts in Haematology – Online Faculty Meeting – September 2023:
2 CPD points
More Details
Haematological considerations for patients with liver disease
Dr Jecko Thachil, Manchester Royal Infirmary
Acquired VWD: Clinical presentations
Dr Gary Benson, Northern Ireland Haemophilia Centre
BSH VWD Guideline update – the way forwards
Dr Will Lester, University Hospital of Birmingham, Queen Elizabeth and Birmingham Women’s Hospital
ADAMTS13 Testing: Issues, stories and solutions
Dr Steve Kitchen, Sheffield Haemophilia and Thrombosis Centre
An educational resource from Grifols

5th AML Academy
Management of Adult AML: Where are we in 2023:
9 CPD points
More Details
This national forum is intended to provide a resource for UK haematologists and research nurses treating patients with AML. Working closely with Charles Craddock, Steve Knapper, Mike Dennis, Mhairi Copland and Victoria Potter it has been possible to create a varied and compelling programme covering many of the recent breakthroughs which are of such importance to our patients.

UK EBMT Nurses and AHP Group Virtual Event – Friday 13th October 2023:
4 CPD points
More Details
Advance care planning
Dr Richard Towers, King’s College Hospital, London
Behavioural science for well-being and recovery
Ross McIntosh, Organisational Psychologist and host of the People Soup Podcast
Lung GVHD – the importance of early detection
Dr Saskia Bos, Newcastle upon Tyne Hospitals
CAR-T service development. Nursing element – ICANS and CRS
Bethany Colton, Sheffield Teaching Hospitals
Professional nurse advocacy in BMT and Aspirant Cancer Career and Education Development (ACCEND)
Sara Main, University Hospital Southampton
EBMT Dietetic Sub-Group: Nutritional support during CAR-T
Natasha Jones (Cambridge) and Nicola Scott (Leeds)
EBMT AHP Sub-Group: Rehabilitation within stem cell transplantation
Orla McCourt, University College London
Registration is free of charge

When Should BRUKINSA▼ (zanubrutinib) Be Your BTK Inhibitor of Choice?
September 2023
More Details
Combining clinical trial evidence and real-world patient management cases, this session will cover where BRUKINSA® could be a treatment option for patients with CLL
Led by Dr Dima El-Sharkawi, The Royal Marsden NHS Foundation Trust
Panel: Dr Piers Patten, Dr Renata Walewska, Dr Talha Munir
An educational resource from BeiGene
Registration is free of charge
Please click here to access the Brukinsa▼ (zanubrutinib) prescribing and adverse event reporting information. Adverse events should be reported via the MHRA Yellow Card Scheme found at www.mhra.gov.uk/yellowcard and also to BeiGene at adverse_events@beigene.com

Real World Experience Treating WM and What’s Next for CLL
July 2023:
1.5 CPD points
More Details
Case-based panel discussion
Led by Professor George Follows, Addenbrooke’s Hospital
Panel: Dr Pam McKay, Beatson West of Scotland Cancer Centre
Dr Sarah Lawless, Belfast City Hospital
Dr Vishal Jayakar, Kingston Hospital
Dr Toby Eyre, Oxford University Hospitals
What’s new in CLL
Dr Toby Eyre, Oxford University Hospitals
An educational resource from BeiGene
Registration is free of charge
Please click here to access the Brukinsa▼ (zanubrutinib) prescribing and adverse event reporting information. Adverse events should be reported via the MHRA Yellow Card Scheme found at www.mhra.gov.uk/yellowcard and also to BeiGene at adverse_events@beigene.com

Haematology Highlights for the UK – Post Summer Congresses – LYMPHOMA + CLL – Thursday 29th June 2023:
6 CPD points
More Details
Advances in the application of radiotherapy
Professor Tim Illidge, The Christie Hospital
Lymphoma biology
Dr Cathy Burton, HMDS, Leeds
25 years of antibody treatment for lymphoma
Professor Peter Johnson, University Hospital Southampton
CAR T cell update
Dr Andrea Kuhnl, King’s College Hospital
Aggressive lymphoma
Professor Chris Fox, Nottingham University Hospitals
Follicular lymphoma
Dr Will Townsend, UCLH
Mantle cell lymphoma
Dr David Lewis, Plymouth University Hospitals
CLL
Dr Piers Patten, King’s College London
T-cell lymphoma
Dr Kate Cwynarski, UCLH
CNS lymphoma
Dr Wendy Osborne, NCCC, Newcastle
Registration is free of charge

Highlights from the ITP Update Day – Friday 12th May 2023:
4 CPD points
More Details
Additional lecture: Pregnancy in ITP
From Professor Jim Bussel, Weill Cornell Medical College, New York
Update on the pathobiology of ITP
Professor John Semple, Lund University, Sweden
Is B cell depletion safe?
Professor Marc Michel, Henri Mondor University Hospital, Paris
How should we use TPO-RA beyond ITP?
Professor Marisa Lozano, University of Murcia, Spain
Older drugs for new regimes
Dr Charlotte Bradbury, University Hospitals Bristol
SYK inhibitor: How to use fostamatinib – the French experience
Dr Guillaume Moulis, Toulouse University Hospital
Debate: TPOs should be used in second line?
For: Dr Drew Provan, Barts & The London School of Medicine, London
Against: Professor Marc Michel, Henri Mondor University Hospital, Paris
Thrombosis in ITP
Professor Waleed Ghanima, Østfold Hospital, Oslo
FcRn inhibition
Professor Francesco Zaja, University Hospital Trieste, Italy
BTK inhibition: The latest data
Professor David Kuter, Massachusetts General Hospital, Boston
Case Presentation: Complications ITP or treatment?
Dr Alice Hart, Imperial College London
What’s on the horizon?
Professor David Kuter, Massachusetts General Hospital, Boston
Registration is free of charge

Highlights from the Transplant and Cell Therapy Updates for the UK virtual meeting – Wednesday 10th May 2023:
4 CPD points
More Details
Updates on GVHD
Professor Mohamad Mohty, Saint-Antoine Hospital, Paris
Updates on lymphoma
Dr Anna Sureda, Catalan Institute of Oncology, Barcelona
BiTEs and other immunotherapies versus CAR T in myeloma
Dr Emma Searle, The Christie Hospital, Manchester
CAR-T therapy for AML: is it realistic?
Dr Sara Ghorashian, GOSH
Advances on prevention and treatment of graft-versus-host-disease
Dr Francesca Kinsella, University of Birmingham
The future of conditioning regimens
Dr Muhammad Saif, Clatterbridge Cancer Centre, Liverpool
AML chemo to transplant
Dr Pramila Krishnamurthy, King’s College Hospital, London
Registration is free of charge

Highlights from the National ALL Update Day – Friday 10th March 2023
2 CPD points
More Details
Adult ALL risk score
Professor Anthony Moorman, Newcastle University
Key challenges, including monitoring of BCR-ABL+ disease
Dr Bela Wrench, Barts Cancer Institute
Management of Philadelphia +ve ALL
Dr Tobias Menne, Newcastle upon Tyne Hospitals
T-cell ALL challenges
Dr Clare Rowntree, University Hospital of Wales
Treatment of relapsed B-cell ALL
Dr Sridhar Chaganti, University Hospitals Birmingham

Post ASH Significant Highlights – MYELOMA – Wednesday 25th January 2023
2 CPD points
More Details
Myeloma frontline
Professor Graham Jackson, NCCC, Newcastle
Relapsed myeloma
Dr Charlotte Pawlyn, Royal Marsden Hospital
Myeloma horizon scanning
Dr Rakesh Popat, UCLH

Post ASH Significant Highlights – LYMPHOMA – Thursday 26th January 2023
3 CPD points
More Details
Lymphoma biology
Dr Jessica Okosun, Barts Cancer Institute
CLL
Dr Piers Patten, King’s College London
MCL and low grade lymphoma
Dr Toby Eyre, Oxford University Hospitals
High grade and CNS lymphoma
Dr Wendy Osborne, NCCC, Newcastle
Hodgkin lymphoma
Professor Graham Collins, Oxford University Hospitals

Immunomodulation Updates – September 2022
6 CPD points
More Details
Register to enjoy the following sessions:
Immunotherapy
Mesenchymal stem cells
Professor Francesco Dazzi, London
Transplant for primary immunodeficiency in adults
Professor Emma Morris, London
Regulatory T cell (TREGs)
Professor Emma Morris, London
GVHD
New agents emerging in GVHD
Professor Ronjon Chakraverty, Oxford
ECP positioning based on RWD and ongoing clinical trails
Dr Francesca Kinsella, Birmingham
UK RATing study for risk adapted therapy for acute GVHD
Professor Adrian Bloor, Manchester
MDT with Difficult Cases
Dr Anjum Khan (Leeds), Dr Harpreet Kaur (Sheffield), Dr Francesca Kinsella (Birmingham)
Question Time
Dr Arun Alfred (Rotherham), Dr Anjum Khan (Leeds), Dr Harpreet Kaur (Sheffield), Dr Francesca Kinsella (Birmingham)
Registration is free of charge for HCPs working within the NHS
Supported by Mallinckrodt

WMUK – Study Day
Updates in Waldenström’s Macroglobulinaemia
4 CPD points
More Details
Overview of WM and 1st line treatments
Dr Shirley D’Sa, UCLH
Latest BSH guidelines on WM – best practice
Dr Dima El-Sharkawi, Royal Marsden
A WM patient discussing their experience
- Patient experience of being diagnosed with WM: Bob Perry, Patient Support Manager WMUK
- Nursing challenges of managing a rare disease: Kerian McDonald and Beccy Veall, Leeds Teaching Hospitals
The holistic approach to management of WM as a multidisciplinary team
Aviva Cerner and Emma Rowles Clinical Nurse Specialists at UCLH
Peripheral neuropathy – cases
Guest Speaker: Dr Aisling Carr, Neurologist, Queen Square Hospital, London
What are the different treatment options 2nd line and beyond in relapse WM
– Regional variations & Clinical trials – what’s available
Dr Jaimal Kothari, Oxford University Hospitals
Supporting the whole family and practical support
- WMUK support line roll out : Alison McKinney, WMUK
- Support Networks: Bob Perry, Patient Support Manager, WMUK
Managing toxicities
- Lucy Whiteman, Royal Marsden and Charlotte Bloodworth, Cardiff
- Nurse Panel: Aviva Cerner, UCLH and Emma Rowles, UCLH
Supported by BeiGene

Hartley Taylor Medical Communications Ltd
2, St George’s Court | St George’s Park
Kirkham | PR4 2EF